Cisplatin

Quantitative prediction of human pharmacokinetic responses to drugs via fluidically coupled vascularized organ chips

Anna Herland, Ben M. Maoz, Debarun Das, Mahadevabharath R. Somayaji, Rachelle Prantil‐Baun, Richard Novák, Michael J. Cronce, Tessa Huffstater, Sauveur S. F. Jeanty, Angeliki Chalkiadaki, David B. Chou, Susan Marquez, Aaron Delahanty, Sasan Jalili‐Firoozinezhad, Yuka Milton, Alexandra Sontheimer-Phelps, Ben Swenor, Oren Levy, Kevin Kit Parker, Andrzej Przekwas, Donald E. Ingber

Citations: 463 • 2020

Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST)

Andreas Hiester, Yue Che, Achim Lusch, Oliver Kuß, Günter Niegisch, Anja Lorch, Christian Arsov, Peter Albers

Citations: 91 • 2022

Robot-guided convection-enhanced delivery of carboplatin for advanced brainstem glioma

Neil U. Barua, Steve Lowis, Max Woolley, S. O’Sullivan, Rob Harrison, Steven S. Gill

Citations: 89 • 2013

A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma

Neil U. Barua, Kirsten Hopkins, Max Woolley, Stephen O’Sullivan, Rob Harrison, Richard Edwards, Alison Bienemann, Marcella Wyatt, Azeem Arshad, Steven S. Gill

Citations: 73 • 2014

Increased Efficiency for Performing Colony Formation Assays in 96-well Plates: Novel Applications to Combination Therapies And High-Throughput Screening

David R. Katz, Emma Ito, Ken S. Lau, Joseph D. Mocanu, Carlo Bastianutto, Aaron D. Schimmer, Fei‐Fei Liu

Citations: 63 • 2008

Safety and effectiveness of pembrolizumab combined with paclitaxel and cisplatin as neoadjuvant therapy followed by surgery for locally advanced resectable (stage III) esophageal squamous cell carcinoma: a study protocol for a prospective, single-arm, single-center, open-label, phase-II trial (Keystone-001)

Xiaobin Shang, Gang Zhao, Fei Liang, Chen Zhang, Wei‐Hong Zhang, Liang Liu, Runmei Li, Xiaofeng Duan, Zhao Ma, Jie Yue, Chuangui Chen, Bin Meng, Xiubao Ren, Hongjing Jiang

Citations: 62 • 2022

Bladder cancer

Carl Bischoff, Peter E. Clark

Citations: 48 • 2009

Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: A case series

Anna Fagotti, Marco Petrillo, Barbara Costantini, Francesco Fanfani, Valerio Gallotta, Vito Chiàntera, Luigi Carlo Turco, Carolina Bottoni, Giovanni Scambia

Citations: 47 • 2014

Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions

Adam Szulkin, Rita Ötvös, Carl-Olof Hillerdal, Aytekin Celep, Eviane Yousef-Fadhel, Henriette Skribek, Anders Hjerpe, László Székely, Katalin Dobra

Citations: 35 • 2014

Perioperative chemoimmunotherapy with durvalumab (Durva) in combination with cisplatin/gemcitabine (Cis/Gem) for operable muscle-invasive urothelial carcinoma (MIUC): Preplanned interim analysis of a single-arm phase II trial (SAKK 06/17).

Richard Cathomas, Ulf Petrausch, Stefanie Hayoz, Martina Schneider, Julian Schardt, Roland Seiler, Andreas Erdmann, Sacha I. Rothschild, Stefanie Aeppli, Nicolas Mach, Raeto T. Strebel, Boris Hadaschik, Dominik Berthold, Miklos Pless, Deborah Zihler, Mathias Schmid, Christine Biaggi Rudolf, Martin Spahn

Citations: 32 • 2020

Nivolumab, nabpaclitaxel, and carboplatin followed by risk/response adaptive de-escalated locoregional therapy for HPV-associated oropharyngeal cancer: OPTIMA II trial.

Ari J. Rosenberg, Nishant Agrawal, Alexander T. Pearson, Tanguy Y. Seiwert, Zhen Gooi, Elizabeth A. Blair, Daniel Thomas Ginat, Adam Howard, Jeffrey Chin, Sara Kochanny, Evgeny Izumchenko, Aditya Juloori, Daniel J. Haraf, Everett E. Vokes

Citations: 30 • 2021

HPV‐associated oropharyngeal cancer de‐escalation strategies and trials: Past failures and future promise

Kaveh Zakeri, Lara Dunn, Nancy Y. Lee

Citations: 24 • 2021

Impact of suboptimal neoadjuvant chemotherapy on peri‐operative outcomes and survival after robot‐assisted radical cystectomy: a multicentre multinational study

Nobuyuki Hinata, Ahmed A. Hussein, Saby George, Donald L. Trump, Ellis Levine, Kawa Omar, Prokar Dasgupta, Muhammad Shamim Khan, Abolfazl Hosseini, Peter Wiklund, Khurshid A. Guru

Citations: 23 • 2016

Nerve sparing retroperitoneal lymph node dissection in clinical stage IIA/B seminoma: The COTRIMS trial.

Axel Heidenreich, Pia Paffenholz, Tim Nestler, David A. Pfister

Citations: 15 • 2022

The PRIMETEST trial: Prospective phase II trial of primary retroperitoneal lymph node dissection (RPLND) in stage II A/B patients with seminoma.

Peter Albers, Achim Lusch, Yue Che, Christian Arsov, Günter Niegisch, Andreas Hiester

Citations: 13 • 2022

Deltonin enhances gastric carcinoma cell apoptosis and chemosensitivity to cisplatin <i>via</i> inhibiting PI3K/AKT/mTOR and MAPK signaling

Lin Yang, Yanan Liu, Yi Gu, Qi Guo

Citations: 11 • 2023

Real-World Study of Adding Bevacizumab to Chemotherapy for Ovarian, Tubal, and Peritoneal Cancer as Front-Line or Relapse Therapy (ROBOT): 8-Year Experience

Pei-Ying Wu, Ya-Min Cheng, Meng‐Ru Shen, Yi-Chun Chen, Yu-Fang Huang, Cheng-Yang Chou

Citations: 10 • 2020

Clinical outcomes of minimally invasive retroperitoneal lymph node dissection and single dose carboplatin for clinical stage IIa seminoma.

Robert Huddart, Alison Helen Reid, Erik Mayer, S.A. Sohaib, David Nicol

Citations: 10 • 2019

Interim analysis of the prospective COTRIMS (Cologne Trial of Retroperitoneal Lymphadectomy in Metastatic Seminoma) trial.

Axel Heidenreich, Felix Seelemeyer, Pia Paffenholz, David A. Pfister

Citations: 8 • 2023

Does MIS Play a Role in the Treatment of Advanced Ovarian Cancer?

Augusto Pereira, Javier F. Magrina, Paul M. Magtibay, João Siufi Neto, Daniela Siufi, Yu‐Hui Chang, Tirso Pérez‐Medina

Citations: 6 • 2022